导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.20% | 220/4773 |
| 近一周 | -2.01% | 1065/5462 |
| 近一月 | 1.04% | 453/5421 |
| 近一季 | 1.57% | 526/5209 |
| 近半年 | -3.65% | 2278/4920 |
| 近一年 | 21.99% | 359/4366 |
| 近两年 | 30.15% | 2263/2954 |
| 近三年 | 18.48% | 1530/2253 |
| 成立以来 | 68.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
18.44% 25/4961 |
-12.82% 4430/5312 |
- - |
- - |
| 2025 | -4.00% 3359/4813 |
-9.32% 3432/3635 |
-1.93% 3285/4076 |
7.70% 3439/4524 |
0.23% 2113/4813 |
| 2024 | -1.62% 2168/3463 |
7.33% 249/2808 |
-0.65% 806/3014 |
3.94% 2912/3129 |
-11.24% 3022/3463 |
| 2023 | 10.95% 82/2656 |
3.29% 1221/2280 |
-5.85% 1548/2385 |
9.66% 6/2515 |
4.04% 38/2655 |
| 2022 | 15.23% 6/2207 |
20.68% 6/1919 |
8.17% 381/2016 |
4.49% 3/2113 |
-15.51% 2077/2208 |
| 2021 | 48.97% 6/1822 |
1.75% 241/1255 |
20.79% 140/1330 |
40.69% 2/1466 |
-13.84% 1629/1822 |
| 2020 | 14.89% 787/1250 |
-15.22% 977/1028 |
1.08% 994/1067 |
12.28% 397/1164 |
19.40% 75/1184 |
| 2019 | 13.14% 712/1092 |
22.18% 576/754 |
-3.79% 410/804 |
-6.72% 816/850 |
3.18% 844/918 |
| 2018 | -32.62% 536/834 |
- - |
- - |
- - |
-12.88% 489/691 |
| 2017 | 8.02% 314/714 |
- - |
- - |
- - |
- - |
| 2016 | 1.54% 94/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 国联中证煤炭指数(LOF)A VS. 长安沪深300非周期A(740101) |